Suvizumab is an experimental antiviral drug and immunomodulator.

It is a monoclonal antibody that binds to HIV-1.

[1] This antiinfective drug article is a stub.

You can help Wikipedia by expanding it.This monoclonal antibody–related article is a stub.

You can help Wikipedia by expanding it.